Jenburkt Pharmaceuticals Ltd

BSE :524731 NSE :- Sector : Pharmac..
1,020.00
Change: 53.30(5.51%)
52 week Low
660.05
52 week High
1,375.00
Day low
956
Day high
1,024.90
Prev Close
966.70
Open
956.00
6M return
9.17%
1Y return
28.63%
MCap(Rs. in Cr.)
426.63
Total Volume
3,667
Face Value : 10
Listed Since
PE Ratio

Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.

P/E RATIO
0
EPS

The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.

EPS
0
PRICE/BOOK

Price-to-book ratio is used to compared the company's current market price with its book value.

PRICE/BOOK
Deliverable

These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.

DELIVERABLES
0
DIV YIELD.(%)

Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.

DIV YIELD.(%)
0

Company Details

Check out the key parameters of the company to understand the financial health and stock performance

Key Level

Resistance 1
-
Resistance 2
-
Support 1
-
Support 2
-

Moving Average

20 Days
-
50 Days
-
100 Days
-
200 Days
-
Growth in 3 years

Sales


Sales Industry Avg


PAT


PAT Industry Avg


No data available
No data available


Relative to Sensex rtn in 3 year


Relative to Nifty rtn in 3 year


Relative to top 3 MF rtn in 3 year


2016 2014 2014
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14

Peer Companies

A quick glance on how stocks from the same sector have performed along with some key parameters

Jenburkt Pharma
1,020.00
Change: 53.30 (5.51%)
1 Year return
28.63%
Risk (Std Dev)
0.13%
PE Ratio
13.58
MCap( in Cr.)
426.63
Fermenta Biotec.
269.35
Change: -9.50 (-3.41%)
1 Year return
33.71%
Risk (Std Dev)
0.17%
PE Ratio
23.10273
MCap( in Cr.)
820.68
Bharat Parenter.
989.55
Change: 47.10 (5.00%)
1 Year return
-11.57%
Risk (Std Dev)
0.28%
PE Ratio
NM
MCap( in Cr.)
649.53
Kerala Ayurveda
315.45
Change: 1.95 (0.62%)
1 Year return
13.51%
Risk (Std Dev)
0.16%
PE Ratio
505.64516
MCap( in Cr.)
377.22
Titan Biotech
445.70
Change: 17.30 (4.04%)
1 Year return
-25.01%
Risk (Std Dev)
0.13%
PE Ratio
15.75000
MCap( in Cr.)
354.02
View More

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

 

If I had made
investment of  
in
Months Ago
My investment would be worth 0 with a of 0%

News

Stay tuned to the latest developments and happenings in the company.

Jenburkt Pharmaceuticals standalone net profit rises 20.56% in the December 2024 quarter

Net profit of Jenburkt Pharmaceuticals rose 20.56% to Rs 6.51 crore in the quarter ended December 2024 as against Rs 5.40 crore during the previous qu....

29 Jan 2025 07:38

Jenburkt Pharmaceuticals to table results

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 January 2025.Powered by Capital Market - Live....

21 Jan 2025 11:06

Jenburkt Pharmaceuticals standalone net profit rises 31.15% in the September 2024 quarter

Net profit of Jenburkt Pharmaceuticals rose 31.15% to Rs 9.60 crore in the quarter ended September 2024 as against Rs 7.32 crore during the previous q....

05 Nov 2024 17:39

Jenburkt Pharmaceuticals to announce Quarterly Result

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 November 2024Powered by Capital Market - Live ....

29 Oct 2024 15:24

Jenburkt Pharmaceuticals standalone net profit rises 38.18% in the June 2024 quarter

Net profit of Jenburkt Pharmaceuticals rose 38.18% to Rs 7.42 crore in the quarter ended June 2024 as against Rs 5.37 crore during the previous quarte....

26 Jul 2024 16:05

Jenburkt Pharmaceuticals to declare Quarterly Result

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 26 July 2024.Powered by Capital Market - Live Ne....

19 Jul 2024 10:24

View More
Subscribe for our
newsletter
Open Account Now